Thus, hPSC-derived pancreatic pseudoislets also known as autologous iPSC-derived β cells potentially offer an alternative inexhaustible source of insulin-producing β-cells for potential diabetes therapy in the future. The gene discussed is INS; the disease is diabetes mellitus.